Bridging DNA damage and cGAS-STING activation: Platinum (IV) prodrugs as single-molecule chemo-immunotherapeutics.
RS-04 achieved potent tumor growth inhibition with markedly reduced systemic toxicity compared to the physical combination of its parent drugs, highlighting the clinical potential of utilizing the Pt (IV) framework as a sophisticated delivery vehicle to synchronize DNA damage with innate immune activation for superior...